Effects of Low Phytanic Acid-Concentrated DHA on Activated Microglial Cells: Comparison with a Standard Phytanic Acid-Concentrated DHA

[1]  Hongguang Chen,et al.  Docosahexaenoic Acid (DHA) Provides Neuroprotection in Traumatic Brain Injury Models via Activating Nrf2-ARE Signaling , 2018, Inflammation.

[2]  F. Kobeissy,et al.  Docosahexaenoic acid (DHA) enhances the therapeutic potential of neonatal neural stem cell transplantation post—Traumatic brain injury , 2018, Behavioural Brain Research.

[3]  A. Waisman,et al.  A novel microglial subset plays a key role in myelinogenesis in developing brain , 2017, The EMBO journal.

[4]  P. Subbaiah,et al.  Dietary docosahexaenoic acid (DHA) as lysophosphatidylcholine, but not as free acid, enriches brain DHA and improves memory in adult mice , 2017, Scientific Reports.

[5]  H. Arai,et al.  Docosahexaenoic acid: one molecule diverse functions , 2017, Critical reviews in biotechnology.

[6]  O. Kuda.  Bioactive metabolites of docosahexaenoic acid. , 2017, Biochimie.

[7]  N. Hayashi,et al.  Identification and detoxification of glycolaldehyde, an unattended bioethanol fermentation inhibitor , 2017, Critical reviews in biotechnology.

[8]  M. Lagarde,et al.  The pleiotropic effects of omega-3 docosahexaenoic acid on the hallmarks of Alzheimer's disease. , 2016, The Journal of nutritional biochemistry.

[9]  K. Soliman,et al.  The Antioxidant Effects of Thymoquinone in Activated BV-2 Murine Microglial Cells , 2016, Neurochemical Research.

[10]  David Heras-Sandoval,et al.  Role of docosahexaenoic acid in the modulation of glial cells in Alzheimer’s disease , 2016, Journal of Neuroinflammation.

[11]  G. Reiser,et al.  Brain Lipotoxicity of Phytanic Acid and Very Long-chain Fatty Acids. Harmful Cellular/Mitochondrial Activities in Refsum Disease and X-Linked Adrenoleukodystrophy , 2016, Aging and disease.

[12]  Xiaolin Yu,et al.  Dietary obesity reversibly induces synaptic stripping by microglia and impairs hippocampal plasticity , 2016, Brain, Behavior, and Immunity.

[13]  A. Salemme,et al.  Anti-inflammatory effects and antioxidant activity of dihydroasparagusic acid in lipopolysaccharide-activated microglial cells , 2016, Brain Research Bulletin.

[14]  H. Nakanishi,et al.  Nutrients, Microglia Aging, and Brain Aging , 2016, Oxidative medicine and cellular longevity.

[15]  O. Garaschuk,et al.  Neuroinflammation in Alzheimer's disease , 2015, The Lancet Neurology.

[16]  M. Arita,et al.  n-3 fatty acids effectively improve the reference memory-related learning ability associated with increased brain docosahexaenoic acid-derived docosanoids in aged rats. , 2015, Biochimica et biophysica acta.

[17]  R. Agrawal,et al.  Interactive actions of Bdnf methylation and cell metabolism for building neural resilience under the influence of diet , 2015, Neurobiology of Disease.

[18]  G. Taglialatela,et al.  NFκB-Activated Astroglial Release of Complement C3 Compromises Neuronal Morphology and Function Associated with Alzheimer’s Disease , 2015, Neuron.

[19]  A. Chauhan,et al.  Glutathione redox imbalance in brain disorders , 2015, Current opinion in clinical nutrition and metabolic care.

[20]  Beilei Lei,et al.  Anti-Inflammatory Effects of Progesterone in Lipopolysaccharide-Stimulated BV-2 Microglia , 2014, PloS one.

[21]  M. O’Banion,et al.  Neuroinflammation and M2 microglia: the good, the bad, and the inflamed , 2014, Journal of Neuroinflammation.

[22]  S. Yuan,et al.  Resolvin D1 promotes the interleukin-4-induced alternative activation in BV-2 microglial cells , 2014, Journal of Neuroinflammation.

[23]  Hung-Chuan Pan,et al.  Docosahexaenoic acid reduces cellular inflammatory response following permanent focal cerebral ischemia in rats. , 2013, The Journal of nutritional biochemistry.

[24]  Y. de Koninck,et al.  Microglia Control Neuronal Network Excitability via BDNF Signalling , 2013, Neural plasticity.

[25]  V. Arora,et al.  Possible Role of Oxidative Stress and Brain Derived Neurotrophic Factor in Triazophos Induced Cognitive Impairment in Rats , 2013, Neurochemical Research.

[26]  Y. Lu,et al.  Spinal injection of docosahexaenoic acid attenuates carrageenan-induced inflammatory pain through inhibition of microglia-mediated neuroinflammation in the spinal cord , 2013, Neuroscience.

[27]  I. Holopainen,et al.  Status epilepticus alters neurogenesis and decreases the number of GABAergic neurons in the septal dentate gyrus of 9-day-old rats at the early phase of epileptogenesis , 2013, Brain Research.

[28]  Chengren Li,et al.  Cuprizone-induced demyelination in mice: age-related vulnerability and exploratory behavior deficit , 2013, Neuroscience Bulletin.

[29]  James H Tadros,et al.  Modulating the inflammatory properties of activated microglia with Docosahexaenoic acid and Aspirin , 2013, Lipids in Health and Disease.

[30]  P. Dutar,et al.  Omega‐3 fatty acids deficiency aggravates glutamatergic synapse and astroglial aging in the rat hippocampal CA1 , 2013, Aging cell.

[31]  Zhenggang Yang,et al.  Omega-3 Polyunsaturated Fatty Acids Antagonize Macrophage Inflammation via Activation of AMPK/SIRT1 Pathway , 2012, PloS one.

[32]  Cristina Viéitez,et al.  Modelling Neuroinflammation In Vitro: A Tool to Test the Potential Neuroprotective Effect of Anti-Inflammatory Agents , 2012, PloS one.

[33]  H. Pereira,et al.  Polyunsaturated Fatty Acids of Marine Macroalgae: Potential for Nutritional and Pharmaceutical Applications , 2012, Marine drugs.

[34]  R. Gibson,et al.  Barramundi (Lates calcarifer) desaturase with Δ6/Δ8 dual activities , 2012, Biotechnology Letters.

[35]  P. Calder.  Mechanisms of action of (n-3) fatty acids. , 2012, The Journal of nutrition.

[36]  L. Videla,et al.  N-3 PUFA Supplementation Triggers PPAR-α Activation and PPAR-α/NF-κB Interaction: Anti-Inflammatory Implications in Liver Ischemia-Reperfusion Injury , 2011, PloS one.

[37]  G. Doherty.  Nitric oxide in neurodegeneration: potential benefits of non-steroidal anti-inflammatories , 2011, Neuroscience Bulletin.

[38]  M. Pugliese,et al.  Oral administration of the KATP channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis , 2011, Journal of Neuroinflammation.

[39]  S. Ferdinandusse,et al.  Phytanic acid metabolism in health and disease. , 2011, Biochimica et biophysica acta.

[40]  G. Reiser,et al.  Phytanic acid and pristanic acid, branched-chain fatty acids associated with Refsum disease and other inherited peroxisomal disorders, mediate intracellular Ca2+ signaling through activation of free fatty acid receptor GPR40 , 2011, Neurobiology of Disease.

[41]  R. Simon,et al.  Pathophysiologically relevant levels of hydrogen peroxide induce glutamate-independent neurodegeneration that involves activation of transient receptor potential melastatin 7 channels. , 2011, Antioxidants & redox signaling.

[42]  Yumin Zhang,et al.  Specific PKC isoforms regulate LPS-stimulated iNOS induction in murine microglial cells , 2011, Journal of Neuroinflammation.

[43]  L. Galland.  Diet and inflammation. , 2010, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[44]  M. Mattson,et al.  Involvement of Fc Receptors in Disorders of the Central Nervous System , 2010, NeuroMolecular Medicine.

[45]  Hee-Yong Kim,et al.  Phosphatidylserine-dependent neuroprotective signaling promoted by docosahexaenoic acid. , 2010, Prostaglandins, leukotrienes, and essential fatty acids.

[46]  C. Dinarello.  Anti-inflammatory Agents: Present and Future , 2010, Cell.

[47]  D. Ganea,et al.  Docosahexaenoic acid prevents dendritic cell maturation and in vitro and in vivo expression of the IL-12 cytokine family , 2010, Lipids in Health and Disease.

[48]  G. Reiser,et al.  The influence of the branched-chain fatty acids pristanic acid and Refsum disease-associated phytanic acid on mitochondrial functions and calcium regulation of hippocampal neurons, astrocytes, and oligodendrocytes , 2009, Neurobiology of Disease.

[49]  Sang Beom Jun,et al.  Docosahexaenoic acid promotes hippocampal neuronal development and synaptic function , 2009, Journal of neurochemistry.

[50]  M. Ihnat,et al.  Docosahexaenoic Acid Inhibits Superoxide Dismutase 1 Gene Transcription in Human Cancer Cells: The Involvement of Peroxisome Proliferator-Activated Receptor α and Hypoxia-Inducible Factor-2α Signaling , 2009, Molecular Pharmacology.

[51]  Zhi-rong Yang,et al.  The influence of orally administered docosahexaenoic acid on cognitive ability in aged mice. , 2009, The Journal of nutritional biochemistry.

[52]  G. Cole,et al.  Omega-3 fatty acids and dementia. , 2009, Prostaglandins, leukotrienes, and essential fatty acids.

[53]  F. Conquet,et al.  Up-Regulation of P2X4 Receptors in Spinal Microglia after Peripheral Nerve Injury Mediates BDNF Release and Neuropathic Pain , 2008, The Journal of Neuroscience.

[54]  D. Lefkowitz,et al.  Microglia and myeloperoxidase: a deadly partnership in neurodegenerative disease. , 2008, Free radical biology & medicine.

[55]  B. Gullberg,et al.  Access to the Published Version May Require Journal Subscription. Published with Permission From: Kluwer Academic Publishers a Prospective Study on Dietary Fat and Incidence of Prostate Cancer (malmö, Sweden) , 2022 .

[56]  Peter Schönfeld,et al.  Fatty acids decrease mitochondrial generation of reactive oxygen species at the reverse electron transport but increase it at the forward transport. , 2007, Biochimica et biophysica acta.

[57]  T. Owens,et al.  Microglial recruitment, activation, and proliferation in response to primary demyelination. , 2007, The American journal of pathology.

[58]  F. Crews,et al.  Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration , 2007, Glia.

[59]  Michal Schwartz,et al.  Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[60]  G. Reiser,et al.  A study of the cytotoxicity of branched-chain phytanic acid with mitochondria and rat brain astrocytes , 2006, Experimental Gerontology.

[61]  S. Moncada,et al.  Nitric oxide, cell bioenergetics and neurodegeneration , 2006, Journal of neurochemistry.

[62]  G. Reiser,et al.  Mechanism of toxicity of the branched-chain fatty acid phytanic acid, a marker of Refsum disease, in astrocytes involves mitochondrial impairment , 2006, International Journal of Developmental Neuroscience.

[63]  G. Reiser,et al.  Rotenone-like Action of the Branched-chain Phytanic Acid Induces Oxidative Stress in Mitochondria* , 2006, Journal of Biological Chemistry.

[64]  J. Glomset.  Role of Docosahexaenoic Acid in Neuronal Plasma Membranes , 2006, Science's STKE.

[65]  Christine M. Williams,et al.  Long-chain n−3 PUFA: plant v. marine sources , 2006, Proceedings of the Nutrition Society.

[66]  G. Reiser,et al.  The Refsum disease marker phytanic acid, a branched chain fatty acid, affects Ca2+ homeostasis and mitochondria, and reduces cell viability in rat hippocampal astrocytes , 2005, Neurobiology of Disease.

[67]  J. Sangiovanni,et al.  The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina , 2005, Progress in Retinal and Eye Research.

[68]  F. Gomez-Pinilla,et al.  Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats. , 2004, Journal of neurotrauma.

[69]  L. Minghetti.  Cyclooxygenase‐2 (COX‐2) in Inflammatory and Degenerative Brain Diseases , 2004, Journal of neuropathology and experimental neurology.

[70]  H. Waterham,et al.  Molecular basis of Refsum disease: Sequence variations in Phytanoyl‐CoA Hydroxylase (PHYH) and the PTS2 receptor (PEX7) , 2004, Human mutation.

[71]  Song‐Pyo Hong,et al.  Novel Docosanoids Inhibit Brain Ischemia-Reperfusion-mediated Leukocyte Infiltration and Pro-inflammatory Gene Expression* , 2003, Journal of Biological Chemistry.

[72]  S. Heales,et al.  Nitric oxide-induced mitochondrial dysfunction: implications for neurodegeneration. , 2003, Free radical biology & medicine.

[73]  Y. Itoyama,et al.  Expression disparity of brain-derived neurotrophic factor immunoreactivity and mRNA in ischemic hippocampal neurons , 2002, Neuroreport.

[74]  D. Miller,et al.  Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: Implications for Parkinson's disease , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[75]  K. Michaelsen,et al.  The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. , 2001, Progress in lipid research.

[76]  I. Black,et al.  Brain-Derived Neurotrophic Factor in Astrocytes, Oligodendrocytes, and Microglia/Macrophages after Spinal Cord Injury , 2000, Neurobiology of Disease.

[77]  J. Martinou,et al.  Mitochondria as the central control point of apoptosis. , 2000, Trends in cell biology.

[78]  M. Lynch,et al.  Age-related changes in synaptic function: analysis of the effect of dietary supplementation with ω-3 fatty acids , 1999, Neuroscience.

[79]  H. Struy,et al.  Refsum disease diagnostic marker phytanic acid alters the physical state of membrane proteins of liver mitochondria , 1999, FEBS letters.

[80]  Geoffrey A. Donnan,et al.  Activated Macrophages and Microglia Induce Dopaminergic Sprouting in the Injured Striatum and Express Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor , 1999, The Journal of Neuroscience.

[81]  A. Roher,et al.  RAGE-Abeta interactions in the pathophysiology of Alzheimer's disease. , 1998, Restorative neurology and neuroscience.

[82]  S. Budd,et al.  Mitochondrial membrane potential and hydroethidine‐monitored superoxide generation in cultured cerebellar granule cells , 1997, FEBS letters.

[83]  T. Molitor,et al.  Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. , 1992, Journal of immunology.

[84]  R. Gibson,et al.  Docosahexaenoic acid synthesis from alpha-linolenic acid is inhibited by diets high in polyunsaturated fatty acids. , 2013, Prostaglandins, leukotrienes, and essential fatty acids.

[85]  M. Block,et al.  NADPH oxidase inhibitor DPI is neuroprotective at femtomolar concentrations through inhibition of microglia over-activation. , 2007, Parkinsonism & related disorders.

[86]  Yan Lu,et al.  Resolvin D1, protectin D1, and related docosahexaenoic acid-derived products: Analysis via electrospray/low energy tandem mass spectrometry based on spectra and fragmentation mechanisms , 2007, Journal of the American Society for Mass Spectrometry.

[87]  S. Rapoport,et al.  n-3 Polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism , 2007, Molecular Psychiatry.

[88]  M. Lynch,et al.  Age-related changes in synaptic function: analysis of the effect of dietary supplementation with omega-3 fatty acids. , 1999, Neuroscience.

[89]  A. Roher,et al.  RAGE-AB Interactions in the Pathophysiology of Alzheimer's Disease , 1998 .

[90]  Carolyn A. Converse,et al.  Lipid studies in retinitis pigmentosa. , 1995, Progress in lipid research.

[91]  W. Smith.  Mechanism of Toxicity. , 1970 .